Search Results - "Bewarder, Moritz"
-
1
Renal AA amyloidosis leading to early diagnosis and treatment of takayasu arteritis: a case report and review of the literature
Published in Clinical research in cardiology (01-11-2020)Get full text
Journal Article -
2
Current Treatment Options in CLL
Published in Cancers (19-05-2021)“…After impressive developments in recent years with the rise of new targeted agents, chemoimmunotherapy (CIT) only plays a minor role in the treatment of…”
Get full text
Journal Article -
3
FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials
Published in European journal of nuclear medicine and molecular imaging (01-10-2021)“…Purpose Fluorine-18 fluorodeoxyglucose positron emission tomography combined with computed tomography (FDG PET/CT) is the standard for staging aggressive…”
Get full text
Journal Article -
4
Prolonged Course of COVID-19-Associated Pneumonia in a B-Cell Depleted Patient After Rituximab
Published in Frontiers in oncology (02-09-2020)“…Patients with pre-existing comorbidities and immunosuppression are at greater risk for SARS-CoV-2 infection and severe manifestations of COVID-19. This also…”
Get full text
Journal Article -
5
Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomas
Published in Scientific reports (26-04-2024)“…Primary vitreoretinal lymphoma (PVRL) is a rare subtype of DLBCL and can progress into primary central nervous system lymphoma (PCNSL). To investigate the role…”
Get full text
Journal Article -
6
A single center retrospective study on real world CAR T-cell therapy: focus on early hematological toxicity
Published in Frontiers in medicine (18-11-2024)“…Patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL) and multiple myeloma have poor outcomes. CAR-T completely…”
Get full text
Journal Article -
7
Impact of vincristine dose reduction on outcomes of patients with aggressive B-cell lymphoma treated with (R) - CHOP
Published in Haematologica (Roma) (01-10-2023)Get full text
Journal Article -
8
Management of Extranodal Marginal Zone Lymphoma: Present and Upcoming Perspectives
Published in Cancers (19-06-2022)“…Extranodal marginal zone lymphoma (EMZL) encompasses a subgroup of non-Hodgkin lymphomas that often present with localized involvement and may manifest in a…”
Get full text
Journal Article -
9
Vitamin D Enhances Immune Effector Pathways of NK Cells Thus Providing a Mechanistic Explanation for the Increased Effectiveness of Therapeutic Monoclonal Antibodies
Published in Nutrients (01-08-2023)“…Patients with diffuse large cell lymphoma who have an adequate vitamin D supply derive significantly more benefit from immuno-chemotherapy with rituximab than…”
Get full text
Journal Article -
10
Adaptive humoral immune response and cellular immune status in cancer patients and patients under immunosuppression vaccinated against SARS-CoV-2
Published in Expert review of vaccines (02-11-2022)“…Patients with cancer and autoimmune diseases are at higher risk of severe COVID-19. They may not develop protective immune responses following vaccination. We…”
Get more information
Journal Article -
11
CD16+ as predictive marker for early relapse in aggressive B-NHL/DLBCL patients
Published in Molecular cancer (28-09-2024)“…Assessing the prognosis of patients with aggressive non-Hodgkin B cell lymphoma mainly relies on a clinical risk score (IPI). Standard first-line therapies are…”
Get full text
Journal Article -
12
B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma
Published in Haematologica (Roma) (01-12-2023)“…Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a Hodgkin lymphoma expressing functional B-cell receptors (BCR). Recently, we described a dual…”
Get full text
Journal Article -
13
Comparison of immersive and non-immersive virtual reality videos as substitute for in-hospital teaching during coronavirus lockdown: a survey with graduate medical students in Germany
Published in Medical education online (31-12-2022)“…As a consequence of the continued Covid-19 lockdown in Germany, in-hospital teaching for medical students was impossible. While lectures and other theoretical…”
Get full text
Journal Article -
14
Role of Specific B-Cell Receptor Antigens in Lymphomagenesis
Published in Frontiers in oncology (09-12-2020)“…The B-cell receptor (BCR) signaling pathway is a crucial pathway of B cells, both for their survival and for antigen-mediated activation, proliferation and…”
Get full text
Journal Article -
15
Insertion site of central venous catheter correlates with catheter-related infectious events in patients undergoing intensive chemotherapy
Published in Bone marrow transplantation (Basingstoke) (01-01-2021)“…Patients undergoing intensive chemotherapy are usually in need for central venous catheters (CVC). Due to contradictory study results, relation of insertion…”
Get full text
Journal Article -
16
Hyper-N-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma
Published in Blood (27-12-2018)“…To address the role of chronic antigenic stimulation in primary central nervous system lymphoma (PCNSL), we searched for autoantigens and identified sterile…”
Get full text
Journal Article -
17
Fewer neurocognitive deficits and less brain atrophy by third ventricle measurement in PLWH treated with modern ART: A prospective analysis
Published in Frontiers in neurology (23-08-2022)“…Background Despite antiretroviral therapy, cognitive dysfunction seems to remain a major issue for people living with human immunodeficiency virus (PLWH)…”
Get full text
Journal Article -
18
Adjuvant Therapy of High-Risk (Stages IIC-IV) Malignant Melanoma in the Post Interferon-Alpha Era: A Systematic Review and Meta-Analysis
Published in Frontiers in oncology (18-02-2021)“…Multiple agents are approved in the adjuvant setting of completely resected high-risk (stages IIC-IV) malignant melanoma. Subgroups may benefit differently…”
Get full text
Journal Article -
19
Characterization of an HLA-restricted and human cytomegalovirus-specific antibody repertoire with therapeutic potential
Published in Cancer Immunology, Immunotherapy (01-08-2020)“…With an infection rate of 60–90%, the human cytomegalovirus (HCMV) is very common among adults but normally causes no symptoms. When T cell-mediated immunity…”
Get full text
Journal Article -
20
Successful treatment of refractory donor‐specific‐human leukocyte antigen‐antibody‐induced primary graft‐failure with daratumumab: A case report
Published in EJHaem (01-08-2024)“…Donor‐specific anti‐human leukocyte antigen (HLA) antibodies represent a main cause of primary graft failure specifically in the setting of haploidentical stem…”
Get full text
Journal Article